Order Article Reprints

Berthelet J, Foroutan M, Bhuva DD, Whitfield HJ, El-Saafin F, Cursons J, Serrano A, Merdas M, Lim E, Charafe-Jauffret E, et al. Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin. Cancers. 2022; 14(10):2404. https://doi.org/10.3390/cancers14102404

Berthelet, Jean, Momeneh Foroutan, Dharmesh D. Bhuva, Holly J. Whitfield, Farrah El-Saafin, Joseph Cursons, Antonin Serrano, Michal Merdas, Elgene Lim, Emmanuelle Charafe-Jauffret, and et al. 2022. "Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin" Cancers 14, no. 10: 2404. https://doi.org/10.3390/cancers14102404

Berthelet, J., Foroutan, M., Bhuva, D. D., Whitfield, H. J., El-Saafin, F., Cursons, J., Serrano, A., Merdas, M., Lim, E., Charafe-Jauffret, E., Ginestier, C., Ernst, M., Hollande, F., Anderson, R. L., Pal, B., Yeo, B., Davis, M. J., & Merino, D. (2022). Computational Screening of Anti-Cancer Drugs Identifies a New BRCA Independent Gene Expression Signature to Predict Breast Cancer Sensitivity to Cisplatin. Cancers, 14(10), 2404. https://doi.org/10.3390/cancers14102404